These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27061460)

  • 1. The Effect of Food on the Intraluminal Behavior of Abiraterone Acetate in Man.
    Geboers S; Stappaerts J; Mols R; Snoeys J; Tack J; Annaert P; Augustijns P
    J Pharm Sci; 2016 Sep; 105(9):2974-2981. PubMed ID: 27061460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: in vitro, rat in situ and human in vivo studies.
    Stappaerts J; Geboers S; Snoeys J; Brouwers J; Tack J; Annaert P; Augustijns P
    Eur J Pharm Biopharm; 2015 Feb; 90():1-7. PubMed ID: 25592324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers.
    Rubbens J; Brouwers J; Tack J; Augustijns P
    Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability Enhancement and Food Effect Elimination of Abiraterone Acetate by Encapsulation in Surfactant-Enriched Oil Marbles.
    Boleslavská T; Rychecký O; Krov M; Žvátora P; Dammer O; Beránek J; Kozlík P; Křížek T; Hořínková J; Ryšánek P; Roušarová J; Canová NK; Šíma M; Slanař O; Štěpánek F
    AAPS J; 2020 Sep; 22(6):122. PubMed ID: 32978690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel monitoring of plasma and intraluminal drug concentrations in man after oral administration of fosamprenavir in the fasted and fed state.
    Brouwers J; Tack J; Augustijns P
    Pharm Res; 2007 Oct; 24(10):1862-9. PubMed ID: 17443397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations of the mechanism behind the rapid absorption of nano-amorphous abiraterone acetate.
    Basa-Dénes O; Solymosi T; Ötvös Z; Angi R; Ujhelyi A; Jordán T; Heltovics G; Glavinas H
    Eur J Pharm Sci; 2019 Mar; 129():79-86. PubMed ID: 30610953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements.
    Solymosi T; Ötvös Z; Angi R; Ordasi B; Jordán T; Semsey S; Molnár L; Ránky S; Filipcsei G; Heltovics G; Glavinas H
    Int J Pharm; 2017 Oct; 532(1):427-434. PubMed ID: 28919099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect.
    Solymosi T; Ötvös Z; Angi R; Ordasi B; Jordán T; Molnár L; McDermott J; Zann V; Church A; Mair S; Filipcsei G; Heltovics G; Glavinas H
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):723-728. PubMed ID: 28776077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate.
    Schultz HB; Meola TR; Thomas N; Prestidge CA
    Int J Pharm; 2020 Mar; 577():119069. PubMed ID: 31981706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration-resistant prostate cancer.
    Chi KN; Spratlin J; Kollmannsberger C; North S; Pankras C; Gonzalez M; Bernard A; Stieltjes H; Peng L; Jiao J; Acharya M; Kheoh T; Griffin TW; Yu MK; Chien C; Tran NP
    J Clin Pharmacol; 2015 Dec; 55(12):1406-14. PubMed ID: 26096139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric and Duodenal Diclofenac Concentrations in Healthy Volunteers after Intake of the FDA Standard Meal: In Vivo Observations and in Vitro Explorations.
    Rubbens J; Brouwers J; Tack J; Augustijns P
    Mol Pharm; 2019 Feb; 16(2):573-582. PubMed ID: 30571131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics.
    Lubberman FJE; Benoist GE; Gerritsen W; Burger DM; Mehra N; Hamberg P; van Oort I; van Erp NP
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1179-1185. PubMed ID: 31515667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal and Systemic Monitoring of Posaconazole in Humans After Fasted and Fed State Administration of a Solid Dispersion.
    Hens B; Corsetti M; Brouwers J; Augustijns P
    J Pharm Sci; 2016 Sep; 105(9):2904-2912. PubMed ID: 27178739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric and Duodenal Ethanol Concentrations after Intake of Alcoholic Beverages in Postprandial Conditions.
    Rubbens J; Riethorst D; Brouwers J; Wolfs K; Adams E; Tack J; Augustijns P
    Mol Pharm; 2017 Dec; 14(12):4202-4208. PubMed ID: 28731350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of new formulation concepts for abiraterone acetate bioavailability enhancement based on the inhibition of pH-induced precipitation.
    Boleslavská T; Světlík S; Žvátora P; Bosák J; Dammer O; Beránek J; Kozlík P; Křížek T; Kutinová Canová N; Šíma M; Slanař O; Štěpánek F
    Eur J Pharm Biopharm; 2020 Jun; 151():81-90. PubMed ID: 32298757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supersaturated-Silica Lipid Hybrids Improve in Vitro Solubilization of Abiraterone Acetate.
    Schultz HB; Joyce P; Thomas N; Prestidge CA
    Pharm Res; 2020 Mar; 37(4):77. PubMed ID: 32236761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of abiraterone acetate oral bioavailability by supersaturated-silica lipid hybrids.
    Schultz HB; Wignall AD; Thomas N; Prestidge CA
    Int J Pharm; 2020 May; 582():119264. PubMed ID: 32278053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, Characterization, and Optimization of a Novel Abiraterone Acetate Formulation to Improve Biopharmaceutical Attributes Aided by Pharmacokinetic Modelling.
    Dahiya S; Savjani K; Savjani J
    AAPS PharmSciTech; 2021 Nov; 23(1):4. PubMed ID: 34811624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Human Duodenal Fluids in Fasted and Fed State Conditions.
    Riethorst D; Mols R; Duchateau G; Tack J; Brouwers J; Augustijns P
    J Pharm Sci; 2016 Feb; 105(2):673-681. PubMed ID: 26228456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.